Overview

Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This is a controlled trial of amantadine to improve level of function following severe traumatic brain injury. The purpose of this study is: 1. To determine whether amantadine hydrochloride, given in a dose of 200-400 mg, improves functional recovery from the vegetative and minimally conscious states 2. To determine whether amantadine-related gains in function persist following drug discontinuation 3. To determine the safety profile of amantadine in patients with disorders of consciousness
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
JFK Medical Center
Collaborator:
U.S. Department of Education
Treatments:
Amantadine